These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21292603)
1. Long-term results after drug-eluting stent implantation in diabetic patients according to diabetic treatment. Voudris V; Karyofillis P; Thomopoulou S; Doulaptsis C; Manginas A; Pavlides G; Cokkinos DV Hellenic J Cardiol; 2011; 52(1):15-22. PubMed ID: 21292603 [TBL] [Abstract][Full Text] [Related]
2. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992 [TBL] [Abstract][Full Text] [Related]
3. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. Abizaid A; Kornowski R; Mintz GS; Hong MK; Abizaid AS; Mehran R; Pichard AD; Kent KM; Satler LF; Wu H; Popma JJ; Leon MB J Am Coll Cardiol; 1998 Sep; 32(3):584-9. PubMed ID: 9741497 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients. van der Hoeven BL; Pires NM; Warda HM; Putter H; Quax PH; Schalij MJ; Jukema JW Int J Cardiol; 2008 Feb; 124(2):166-71. PubMed ID: 17408773 [TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial. Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ; Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659 [TBL] [Abstract][Full Text] [Related]
6. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry. Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734 [TBL] [Abstract][Full Text] [Related]
8. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974 [TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353 [TBL] [Abstract][Full Text] [Related]
10. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
11. Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients. Tamburino C; Ciriminna S; Barbagallo R; Galassi AR; Ussia G; Capranzano P; Tagliareni F; Tolaro S; Nicosia A; Stabile A; Grassi R; Fiscella A; Patti A; Saccone G J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):161-8. PubMed ID: 18192809 [TBL] [Abstract][Full Text] [Related]
12. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
13. The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. Grube E; Chevalier B; Guagliumi G; Smits PC; Stuteville M; Dorange C; Papeleu P; Kaul U; Džavík V Am Heart J; 2012 May; 163(5):867-875.e1. PubMed ID: 22607866 [TBL] [Abstract][Full Text] [Related]
14. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction. Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756 [TBL] [Abstract][Full Text] [Related]
15. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029 [TBL] [Abstract][Full Text] [Related]
16. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445 [TBL] [Abstract][Full Text] [Related]
17. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939 [TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction. De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193 [TBL] [Abstract][Full Text] [Related]
19. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802 [TBL] [Abstract][Full Text] [Related]
20. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]